Sigma Africa Healthcare

Cancer is a devestating disease but when diagonised early can be managed and treated, The vision and plan for Sigma Africa Healthcare is focused on providing innovative AI cancer and diabetes type 2 screening and diagnostic tool. OPHTASCAN is non invasive, easy to use, affordable, effective, efficient and reliable. OPHTSCAN an AI application screening tool for the main gynecological cancers (cervical cancer, breast cancer, uterus cancer) and other cancers such as prostate cancer and lung cancer. The simplicity of the technology that needs only a smartphone to take pictures of the iris and upload them into the software developed to get the risk of those oncological pathologies in a few minutes is just amazing. Our aim is to improve health outcomes in Africa and we are excited to be working with partners in DRC, Uganda, Namibia, Kenya, Cameroon, South Africa, Ivory Cost and Central African Republic . OPHTASCAN is set to be a game-changer is screening and diagonosis of cancer and diabetes type 2 because it offers remote medical diagnosis at a very low cost per use, presenting excellent value to patients and healthcare providers. It's easy to screen large numbers of patients and the test only takes a matter of seconds.